C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2002
12/05/2002	WO2002096944A2 New heterotetrameric potassium channels and uses thereof
12/05/2002	WO2002096943A1 Stat6-activating genes
12/05/2002	WO2002096942A2 Recombinant dna encoding the major allergen of plantago lanceolata pollen pla l 1, and applications thereof
12/05/2002	WO2002096941A2 Polypeptide which reacts with the antibodies of patients infected by hcv and uses thereof
12/05/2002	WO2002096940A2 Attenuated very virulent infectious bursal disease virus
12/05/2002	WO2002096939A2 Adenovirus protein ix, its domains involved in capsid assembly, transcriptional activity and nuclear reorganization
12/05/2002	WO2002096938A2 Human kunitz-type protease inhibitor
12/05/2002	WO2002096937A2 Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases
12/05/2002	WO2002096935A2 Long lasting fusion peptide inhibitors for hiv infection
12/05/2002	WO2002096932A1 Transporters and ion channels
12/05/2002	WO2002096929A2 Polypeptides reacting with hcv-infected patients' antibodies and uses
12/05/2002	WO2002096924A1 Kindling fluorescent proteins and methods for their use
12/05/2002	WO2002096467A2 Pharmaceutical use for secreted bacterial effector proteins
12/05/2002	WO2002096459A1 Tumor therapy
12/05/2002	WO2002096454A1 Recombinant molecules with reduced immunogenicity, methods and intermediates for obtaining them and their use in pharmaceutical compositions and diagnostic tools
12/05/2002	WO2002096452A1 Siglec-12 polypeptides, polynucleotides, and methods of use thereof
12/05/2002	WO2002096396A1 Fine inorganic particles having drug included therein, method for preparation thereof and pharmaceutical preparation comprising fine inorganic particles having drug included therein
12/05/2002	WO2002096390A1 Neutral-cationic lipid for systemic delivery of factor viii gene
12/05/2002	WO2002096364A2 Feline bronchioloalveolar lung carcinoma xenograft and cell line
12/05/2002	WO2002096356A2 HIGH AFFINITY LIGAND FOR p75 NEUROTROPHIN RECEPTOR
12/05/2002	WO2002096355A2 Compositions and methods for adipose abundant protein
12/05/2002	WO2002096350A2 Immunogenic peptide composition for the prevention and treatment of alzheimer's disease
12/05/2002	WO2002096349A2 Vaccination against the feline immunodeficiency virus
12/05/2002	WO2002070557A3 Nuclear hormone receptor ligand binding domain
12/05/2002	WO2002070546A3 Modified derivatives of cck-8
12/05/2002	WO2002070018A3 Tetradentate peptide-chelate conjugates for colorectal cancer diagnosis
12/05/2002	WO2002068470A3 Interferon-alpha induced gene
12/05/2002	WO2002064802A3 Regulatory genes suitable for use in gene expression
12/05/2002	WO2002064757A3 Influenza viruses with enhanced transcriptional and replicational capacities
12/05/2002	WO2002063018A8 Method for the production of plant seed with modified fibre content and modified seed coat
12/05/2002	WO2002062957A9 Ter sites and ter binding proteins
12/05/2002	WO2002062822A3 Methods of identifying regulator molecules
12/05/2002	WO2002060924A9 Identification and applications of porcine reproductive and respiratory syndrome virus host susceptibility factor(s) for improved swine breeding and development of a non-simian recombinant cell line for propagation of the virus and a target for a novel class of antiviral compounds
12/05/2002	WO2002059150A3 Materials and methods relating to protein aggregation in neurodegenerative disease
12/05/2002	WO2002059146A3 Peptides having affinity for the gp120 viral protein and use thereof
12/05/2002	WO2002056902A3 Ccr5 antagonist and dp-178 polypeptide for treating viral infections
12/05/2002	WO2002055655A3 Metylococcus capsulatus genes and dna array for the determination of gene expression in metylococcus capsulatus
12/05/2002	WO2002055553A3 Nucleotide sequences and protein(s) encoded by such nucleotides for modulation of apoptosis
12/05/2002	WO2002051866A3 Antibacterial treatments
12/05/2002	WO2002051863A3 Polypeptides having a triggering nk activity and biological applications
12/05/2002	WO2002048384A3 Nucleic acid sequence 'm73791' serving as a human gene, and derivatives thereof
12/05/2002	WO2002046221A3 Human protein differentially expressed in alzheimer's disease's brain
12/05/2002	WO2002042327A3 Cocoa albumin and its use in the production of cocoa and chocolate flavour
12/05/2002	WO2002042321A3 Mixed fibrils
12/05/2002	WO2002040511A3 Dna sequence and microcine from escherichia coli strain dsm 6601
12/05/2002	WO2002028902A3 Nectin polypeptides, polynucleotides, methods of making and use thereof
12/05/2002	WO2002028351A9 Recombinant mucin binding proteins from steptococcus pneumoniae
12/05/2002	WO2002020766A3 G-csf analog compositions and methods
12/05/2002	WO2002016413A3 Cripto tumour polypeptide
12/05/2002	WO2002012468A3 2,5-dkg permeases
12/05/2002	WO2002008266A3 Complete nucleotide sequence of staphylococcus aureus ribosomal protein s16 gene and methods for the identification of antibacterial substances
12/05/2002	WO2002000715A3 Mammal 2p domain mechano-sensitive k+ channel, cloning and applications thereof
12/05/2002	WO2001097608A3 Cyk-4 polypeptides, dna molecules encoding them and their use in screening methods
12/05/2002	WO2001096391A3 55p4h4: gene expressed in various cancers
12/05/2002	WO2001094605A3 Recombinant aav vectors for gene therapy of obesity
12/05/2002	WO2001090142A3 FULL LENGTH HUMAN HCN1 Ih CHANNEL SUBUNIT AND VARIANTS
12/05/2002	WO2001088085A3 Novel bee venom polypeptides and methods of use thereof
12/05/2002	WO2001085948A3 Nucleotide sequences which code for the coryneform acyl carrier protein gene
12/05/2002	WO2001085947A3 Compounds and methods for the diagnosis and treatment of babesia microti infection
12/05/2002	WO2001083518A9 Molecules that modulate ubiquitin-dependent proteolysis and methods for identifying same
12/05/2002	WO2001079448A3 Trp8, a transient receptor potential channel expressed in taste receptor cells
12/05/2002	WO2001073016A3 Regulation of human tap-related protein
12/05/2002	WO2001064949B1 Diagnostics and therapeutics for glaucoma
12/05/2002	WO2001062928A3 Polypeptides and nucleic acids encoding same
12/05/2002	WO2001060397A9 Uses of agonists and antagonists to modulate activity of tnf-related molecules
12/05/2002	WO2001053456A9 Methods and materials relating to prothrombinase-like polypeptides and polynucleotides
12/05/2002	WO2001053454A9 Methods and materials relating to g protein-coupled receptor-like polypeptides and polynucleotides
12/05/2002	WO2001049743A9 Methods of modulation of the immune system
12/05/2002	WO2001045638A3 Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death
12/05/2002	WO2001044816A9 Conformational and topological protein regulation
12/05/2002	WO2001032926A3 Differentially expressed genes involved in angiogenesis, the polypeptides encoded thereby, and methods of using the same
12/05/2002	WO2001021796A9 Gl50 molecules and uses therefor
12/05/2002	WO2001019958A9 Stabilized soluble glycoprotein trimers
12/05/2002	WO2001019408A9 Nucleic acids encoding polyepitope polypeptides
12/05/2002	US20020184659 Nucleotide sequences coding polypeptides for use as tools in controlling gene expression in plants
12/05/2002	US20020184656 In vivo assay system for screening and validation of drugs and other substances
12/05/2002	US20020183934 Methods for making character strings, polynucleotides and polypeptides having desired characteristics
12/05/2002	US20020183509 Generation of preferential nucleotide sequences library; obtain nucleotide sequences, denature, hybridize to primers, remove and recover nucleotide sequences expressing signal
12/05/2002	US20020183508 Sequences of hepatitis C virus genotypes and their use as prophylactic, therapeutic and diagnostic agents
12/05/2002	US20020183507 Novel human GABA receptor proteins and polynucleotides encoding the same
12/05/2002	US20020183505 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/05/2002	US20020183503 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of immunological, infectious, inflammatory and cancer disorders
12/05/2002	US20020183501 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of mammary gland cancer
12/05/2002	US20020183500 Nucleotide sequence coding polypeptide for use in the treatment, diagnosis, classification and imaging of lung cancer
12/05/2002	US20020183496 Human thymosin beta15 gene, protein and uses thereof
12/05/2002	US20020183494 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/05/2002	US20020183493 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/05/2002	US20020183492 Isolation of biopolymers from human serum albumin; obtain human serum albumin, expose to ion exchange resin, elute and recover biopolymer
12/05/2002	US20020183491 Methods for the isolation of proteinase inhibitor from potato tubers
12/05/2002	US20020183488 Protein composition and process for isolating a protein composition from a muscle source
12/05/2002	US20020183485 Nucleotide sequences coding receptor protein for use in the treatment of hypertriglyceridaemia, inflammation, cachexia, infections and tumors
12/05/2002	US20020183484 Immunogenic formulation and process for preparation thereof
12/05/2002	US20020183483 Method for purification of molecules using unbranched terminal alkyldiols
12/05/2002	US20020183276 Administering alkaline phosphatase (TNAP) inhibitor to the tissue or patient effective to inhibit TNAP expression or activity for decreasing matrix mineralization in a tissue
12/05/2002	US20020183274 Plant breedig; for producing hybrid seeds
12/05/2002	US20020183273 Compositions and methods for improving kidney function
12/05/2002	US20020183272 Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of chlamydia
12/05/2002	US20020183270 For therapy of cancer and for diagnosing tumorigenicity and other diseases
12/05/2002	US20020183269 Novel compounds
12/05/2002	US20020183268 Coding sequences of the human BRCA1 gene

1 ... 1706 1707 1708 1709 1710 1711 1712 1713 1714 1715 1716 1717 1718 1719 1720 1721 1722 1723 1724 1725 1726 ... 2916